Exogenous surfactant, a role in the adult acute respiratory distress syndrome?

Exogenous surfactant, a role in the adult acute respiratory distress syndrome?

Authors

  • S. Busani
  • M. Girardis
  • A. Pasetto, et al.

Keywords:

Exogenous surfactant, ARDS, hypoxia, mechanical ventilation

Abstract

Adult ARDS still represents a high mortality disease. Exogenous surfactant trials in adults with ARDS failed to prove benefit on survival; anyway limitations of these studies were strongly debated. An Italian group of intensive care doctors, proceeding from trials observations, shared an exogenous surfactant protocol for the treatment of ARDS in adult patients.

Downloads

Published

01-07-2012

Issue

Vol. 83 No. 1 (2012): Supplement

Section

Session 3 – Clinical perspectives

License

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. 
Authors retain the copyright for their published work. No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

How to Cite

1.
Busani S, Girardis M, Pasetto, et al. A. Exogenous surfactant, a role in the adult acute respiratory distress syndrome?. Acta Biomed [Internet]. 2012 Jul. 1 [cited 2024 Jul. 27];83(1):56-9. Available from: https://mattioli1885journals.com/index.php/actabiomedica/article/view/2366